Ocrelizumab treatment in multiple sclerosis: A Danish population‐based cohort studyLuigi Pontieri, Melinda Magyari, Henrik Kahr Mathiesen et al.|European Journal of Neurology|2021Cited by 29
The effectiveness of natalizumab vs fingolimod–A comparison of international registry studiesJohanna Balslev Andersen, Gilles Edan, Murat Terzi et al.|Multiple Sclerosis and Related Disorders|2021Cited by 12